<DOC>
	<DOCNO>NCT01591044</DOCNO>
	<brief_summary>The purpose study determine safety , efficacy tolerability R940343 treatment mild moderate asthma .</brief_summary>
	<brief_title>A Safety Efficacy Study Inhaled R940343 Patients With Mild Moderate Asthma</brief_title>
	<detailed_description>The study multi-center , randomize , double-blind , placebo-controlled , parallel group study compare 2 dos inhaled R343 bid placebo 8 week patient mild moderate allergic asthma . Patients meet specific inclusion exclusion criterion initial screen evaluation single-blind , run-in period randomize receive either R343 placebo .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Clinical history asthma Ability perform spirometry Chronic obstructive pulmonary disease bronchiectasis Upper low respiratory infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>